Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma
Clinical trial NCT01405963 · COMPLETED
Trial details
- NCT number
- NCT01405963
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-31
- Primary completion
- 2013-04-05
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.